Asian American, Native Hawaiian, and Pacific Islander (AANHPI) people represent one of the largest and most rapidly growing groups in the United States and are often aggregated as a homogeneous, rather than diverse, population in medical research and education. Currently, few educational interventions focus on the disaggregation of AANHPI patient populations and the improvement of knowledge about health disparities that affect AANHPI patients. We developed, implemented, and facilitated a workshop for medical students to address AANHPI health disparities, adaptable for in-person and online formats. The 1-hour session involved a preworkshop evaluation; a PowerPoint presentation outlining the history of the Asian monolith bias, health disparities within AANHPI subgroups, and strategies for health care professionals and trainees to engage effectively with these communities; and a postworkshop evaluation. Pre- and postworkshop evaluations assessed participants' confidence and understanding of AANHPI health disparities. Additionally, the postworkshop evaluation gathered feedback on the presentation. Pre- and postworkshop evaluations revealed that this workshop, attended by 42 diverse participants over two sessions, significantly improved participants' understanding of the Asian monolith bias and AANHPI health care disparities (p < .05). Whether attending virtually or in person, participants reported notable improvements in their self-evaluated confidence in treating AANHPI patients. The AANHPI patient population comprises a myriad of different cultures, historical contexts, and health needs. We present an educational module that is associated with significant improvement of knowledge about health disparities specific to this population, informing further efforts in cultural competence within medical education.
20 August 2025 in Ophthalmic Plastic & Reconstructive Surgery
Purpose: To describe the clinical, histologic, and molecular features of a rare case of orbital synovial sarcoma and to provide a comprehensive literature review. Methods: The authors present a case report and up-to-date literature review of orbital synovial sarcoma. Variables analyzed included patient demographics, clinical presentations, imaging findings, histopathologic features, molecular diagnostics, treatment, and outcomes. Results: A 25-year-old female presented with a left orbital mass causing swelling, tearing, and mild vision impairment. Imaging identified a mass in the inferior orbit, which was subsequently confirmed by pathology as a monophasic spindle cell synovial sarcoma. Notably, initial fluorescence in situ hybridization testing for the SS18 rearrangement was negative; however, next-generation sequencing later identified an SS18-synovial sarcoma X breakpoint protein 2 fusion. The patient underwent complete surgical resection, followed by proton beam radiotherapy and chemotherapy. A PubMed and Medline search revealed 10 prior cases of orbital synovial sarcoma. Most patients were female (90.9%) and presented with painless swelling, lacrimation, and headaches. All tumors were localized at diagnosis. Surgical resection was the primary treatment in 81% of cases, with adjuvant radiation or chemotherapy each administered in 36% of cases. No recurrence or metastasis was observed on follow-up (average 11.6 months). Conclusions: Orbital synovial sarcoma is rare and typically localized at diagnosis. This is the first reported orbital synovial sarcoma with an SS18–synovial sarcoma X breakpoint protein 2 fusion identified by next-generation sequencing after negative fluorescence in situ hybridization. The case underscores the diagnostic value of molecular profiling when standard testing is inconclusive.